Event Honored Barney Cohen, Managing Director and Wealth Partner at J.P. Morgan Wealth Management and showcased designer Josie Natori’s Spring 2024 collection at the Elegant Riverpark Restaurant. The10th Annual Waxman Luncheon, benefiting the Samuel Waxman Cancer Research Foundation (SWCRF), took place in New York City at a new venue, Riverpark. The fundraising event featured a live, thrilling fashion show by legendary designer, Josie Natori, showcasing the Spring 2024 collection. This year’s honoree was Barney Cohen, Managing Director and Wealth Partner at J.P. Morgan Wealth Management, was recognized for his commitment to supporting collaborative cancer research.
More than 150 guests attended the affair and helped raise nearly $175,000 to support crucial SWCRF initiatives such as the International Network on Aging and Cancer and the Women’s Cancer Research Program.
In addition to the fashion presentation, guests were treated to an exciting live auction and had the opportunity to win a Mikimoto Akoya Cultured Pearl and Diamond Pendant valued at $16,000, donated by Mikimoto.
Waxman Luncheon Chairs included: Chairs Marion N. Waxman, Jani Gerard, and Erica Linden-Fineberg; Co-Chairs Dina Koutroumanis, Nancy Litman, Lauren Silvers, and Helen Vaysman. The Committee included Karen Giberson, Leena Gurevich, Orital Karelic, Regina Kravitz, Norah Lawlor, Lorri Scott, Jean Shafiroff, and Bettina Waxman.
Notable Attendees included: Barney Cohen, Rachelle Cohen , Josie Natori, Dr. Samuel Waxman, Marion Waxman, Jani Gerard, Kobi Halperin, Helen Vaysman, Ruth Rozenholcabend, Alyssa Klein, Nancy Litman, Lauren Silvers, Brooke Herman Zarkowsky, Jean Shafiroff, Maria Fishel, Mariebel Lieberman, and Ann Liguori.
J.P. Morgan was the Luncheon sponson and in-kind donors included Mikimoto, Natori, Palm Bay International, Neuhaus Chocolates, Kobi Halperin, Arlotta Cashmere, Fendi, Movdo Group, Inc., Sachin & Babi, Jimmy Choo, Jil Sander, Chloé, Carlos Falchi, Maximilian, and many more. Flowers provided courtesy of ByRobin Event Design and Management Group.
Since 1976, SWCRF has invested more than $120 million towards collaborative, cross-institutional research, supporting more than 200 investigators around the world.
The SWCRF philosophy of collaboration has led to breakthrough discoveries such as a treatment for acute promyelocytic leukemia (APL), developed in collaboration with researchers at the Shanghai Institute of Hematology that improved the survival rate to 95% (APL had an 80% fatality rate). Most recently, research funded by SWCRF led to an FDA approved medication shown to reduce lung cancer tumors by up to 50% by targeting the KRAS protein, helped develop an innovative two-drug therapy to better treat brain tumors which are often difficult to target, and studies exploring how aging impacts the spread of ovarian cancer in older patients. Several other studies are in clinical trials.
About The Samuel Waxman Cancer Research Foundation:
The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $120 million to support the work of more than 200 researchers across the globe.
10th Annual Luncheon 2024 Cancer Research Charity Event Fundraising Samuel Waxman Cancer Research Foundation SWCRF
Last modified: May 20, 2024
